Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
<p>Abstract</p> <p>Background</p> <p>Neuropathological, animal, and cell culture studies point to a role for the body's own endogenous cannabinoids (eCBs) system in Alzheimer's disease (AD) pathology and treatment. To date, no published studies have investigat...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/8/1/2 |